Impact of Microorganisms

TWiM #221: Weapon of Mucus Destruction, WMD

Podcast and Annotation Information
  • Annotation by Izabella Lima, Kris Anders, Gabrielle Guida, Ramaydalis Keddis, and Rebecca Seipelt-Thiemann
  • Podcast audio by TWiM: Listen to TWiM #221 Podcast
  • Podcast transcript by Otter.ai and edited by Grace Helle and Harshita Sharma: Access Podcast Transcripts
  • Papers Discussed:
    • Rouillard KR, Markovetz MR, Bacudio LG, Hill DB, Schoenfisch MH. 2020. Pseudomonas aeruginosa Biofilm Eradication via Nitric Oxide-Releasing Cyclodextrins. ACS Infectious Diseases. 6(7):1940–1950. doi: 10.1021/acsinfecdis.0c00246
    • Kenny DJ, Plichta DR, Shungin D, Koppel N, Hall AB, Fu B, Vasan RS, Shaw SY, Vlamakis H, Balskus EP, et al. 2020. Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level. Cell Host & Microbe. 28(2):245-257.e6. doi: 10.1016/j.chom.2020.05.013.

1. Paper Abstracts

1.1. Snippet paper; discussion starts at 6:15 minutes

The Most Interesting Things (according to students)

When you rub your hands with hand sanitizer, the rubbing does a lot of getting rid of pathogens.

This article is not licensed for Creative Commons use. Thus, the abstract and figures cannot be copied here. Please see the article on the journal’s website.

1.2. Main paper; discussion starts at 31:38 minutes

The Most Interesting Things (according to students)

Loss of function frameshift mutations are typically detrimental, but in the case of the rpoB gene mutation in Mycobacterium tuberculosis, it resulted in advantageous antibiotic resistance.

“The human microbiome encodes extensive metabolic capabilities, but our understanding of the mechanisms linking gut microbes to human metabolism remains limited. Here, we focus on the conversion of cholesterol to the poorly absorbed sterol coprostanol by the gut microbiota to develop a framework for the identification of functional enzymes and microbes. By integrating paired metagenomics and metabolomics data from existing cohorts with biochemical knowledge and experimentation, we predict and validate a group of microbial cholesterol dehydrogenases that contribute to coprostanol formation. These enzymes are encoded by ismA genes in a clade of uncultured microorganisms, which are prevalent in geographically diverse human cohorts. Individuals harboring coprostanol-forming microbes have significantly lower fecal cholesterol levels and lower serum total cholesterol with effects comparable to those attributed to variations in lipid homeostasis genes. Thus, cholesterol metabolism by these microbes may play important roles in reducing intestinal and serum cholesterol concentrations, directly impacting human health.” (Kenny et al. 2020)

2. Vision and Change Core Concepts and 2024 ASM Fundamental Statements

Snippet Main
Vision and Change Topics
  • Structure and Function (V&C_SF)
  • Impact of Microorganisms (V&C_IM)
  • Information Flow and Genetics (V&C_IFG)
  • Metabolic Pathways (V&C_MP)
  • Impact of Microorganisms (V&C_IM)
ASM Fundamental Statements
  • Fundamental Statement 6 (ASM_6): The distinct structures and processes in microbes can be targets for interspecies competition, antimicrobial treatments, and host immunity
  • Fundamental Statement 29 (ASM_29): The extent of microbial damage can be minimized by host-derived and external factors, including the microbiome, antibiotics, and immunity.
  • Fundamental Statement 13 (ASM_13): Intrinsic factors, such as genotype, metabolism, and cell structures, impact the survival and growth of microbes.
  • Fundamental Statement 18 (ASM_18): The regulation of gene expression is influenced by external and internal molecular cues and signals.
  • Fundamental Statement 27 (ASM_27): The extent of microbial diversity is largely unknown, and exploration of this diversity is critical to understanding microbes and their role in the biosphere.

3.  Potential Learning Objectives for the Podcast

The student will be able to: Paper1 Order2
  • Recall factors affecting severity and antibiotic resistance in cystic fibrosis patients.
  • Identify ways in which nitrous oxide disrupts Pseudomonas aeruginosa biofilms.
S L
  • Predict how the experimental outcome would be changed if the CD-NO action was different.
S H
  • Identify the biological functions of cholesterol.
  • Identify the bacterial genus with the most ismA homologs.
  • Identify the type and role of the various -omic databases used in the identification of cholesterol-oxidizing enzyme IsmA.
M L
  • Design an experiment to identify whether a newly sequenced genome has an ismA homolog.
M H

1 Papers: Snippet (S) or Main (M)

2 Learning Objectives: Lower Order or Higher Order (H)

4. Techniques Described (with Time Stamps)

Here is a link to a bio-dictionary that has many, but not all definitions if you need a definition: Explore Biology Bio-Dictionary

4.1. Snippet Paper

  • Delivery Systems (17:18–20:58; 30:05–30:28): In order for a drug to be effective it must be delivered efficiently.  Here, the researchers test two different types of delivery vehicles (chitosan and beta-cyclodextrin) for their effectiveness in delivering nitrous oxide and breaking up the biofilm formation. Chitosan effectively released nitrous oxide but hardened and compressed the biofilm, making it difficult for the nitrous oxide to break up the mucus. The presence of protons in an acidic environment allows beta-cyclodextrin (CD) to release nitrous oxide quickly in relevant concentration that can be sustained for hours, since this molecule is small and can easily invade the biofilm.
  • Enrichment Media (19:09–19:26): Media is used in the laboratory to culture microbes based on their nutritional requirements.  It can be enriched with compounds that are expected to enhance cell or bacterial growth. In this scenario Pseudomonas aeruginosa‘s behavior was examined  when it was  grown on different media, i.e., TSA, sputum, porcine gastric mucins  and sputum filtrate medium (sputum was isolated from a CF patient) to evaluate its ideal conditions when forming biofilm
  • Antimicrobial Susceptibility Test (23:55–24:25): This assay is also called disk diffusion assay or Kirby-Bauer susceptibility test.  It is a test for a bacterium’s antibiotic sensitivity and typically involves placing a paper disk impregnated with a compound onto a lawn of bacteria and looking for a zone of inhibited growth around the disk.  This experiment used three commonly used antibiotics currently used to treat cystic fibrosis which included tobramycin cyclodextrin, and colistin. Resistance to antibiotics would show continuous growth, while susceptibility would display extinction of the biofilm.

4.2. Main Paper

  • Molecular and Biochemical Techniques (31:38–39:35): Utilizing DNA changes (mutagenesis) and the associated biochemical techniques of epitope tagging and metabolite level quantification, the researchers confirmed that ismA encodes a protein that can convert cholesterol to coprostanol, is oxygen-independent, requires NADP, is found in fecal samples when cholesterol metabolites are high, and homologs are present in a large number of species, particularly in the Clostridium genus.
  • Metabolomics (38:50–39:38): This is a high throughput method for identifying and quantifying metabolites in a mixture.  Stool metabolomes were analyzed for coprostanol, the end product of cholesterol degradation, which allowed identification of cholesterol-relevant protein clusters. This was then used to identify putative genes for degrading cholesterol to coprostanol.
  • Enzymatic/Tissue Lysate Preparation  (39:35–52:28): Lysates are cell-free homogenates made by lysing cells.  Here, the researchers utilized different lysate types to determine whether Eubacterium have the enzymes available to degrade cholesterol to cholestenone, allowing the genes to be narrowed down
  • Bioinformatics (39:35–52:28): Bioinformatics uses computational approaches to analyze large datasets.  Here, it was used in a number of ways to identify species and genes in bacteria that can alter cholesterol and when present in gut bacteria influence host gut cholesterol and serum cholesterol levels.
  • Metagenome Bioinformatics (48:10–52:00): Metagenome sequences are pools of DNA sequences isolated from an environmental source to identify the species present, such as in the gut microbiome.  Here, metagenomic sequences from fecal samples were used to identify bacteria that were correlated with the presence of known cholesterol metabolites.  Through a series of adjustments, the researchers were able to also the identify putative genes involved. These were then compared to available databases in order to identify homologous genes.

5. Connections to General Microbiology Processes/Concepts (with Time Stamps)

5.1. Snippet Paper

  • Biofilms (6:15–15:51): Pseudomonas aeruginosa congregates in a thin, slimy layer within the lungs. The slime layer is made of water and EPS (extra polysaccharides) which inhibits antibiotic action on these microbes.
  • Virulence Factor (6:55–7:30): Pseudomonas aeruginosa is capable of creating a biofilm over the surfaces it infects. This capability contributes to its virulence and the reason it’s so difficult to treat.
  • Antibiotic Resistance (10:17–11:20): Pseudomonas aeruginosa is a bacterium that is able to resist antibiotics because of the biofilm layer it creates. This means that the biofilm will still grow on the surface that is treated with antibiotics.

5.2. Main Paper

  • Human Microbiomes (33:19–34:52; 47:07–51:04): These cholesterol-oxidizing bacteria are found in human gut microbiomes. The authors use human fecal microbiomes to examine the genes these bacteria possess
  • Genomics ( 34:57–40:55; 48:10–52:00): This is the study of an organism’s complete set of DNA (genome).
  • Enzymatics (43:45- 44:10): This is studying the reactions catalyzed by enzymes. In this study, they examine the genes and proteins associated with converting cholesterol to coprostanol and intermediate cholestenone

6. Podcast Questions

  1. Which factors contribute to the severity of cystic fibrosis? [pick all that apply]
    1. Quorum sensing of P. aeruginosa
    2. Charge of the gut environment
    3. Biofilm formation in the lung
    4. Blocking host endocytosis
  2. In what ways does the presence of extracellular DNA and other negatively charged molecules present in the biofilm contribute to antibiotic resistant P. aeruginosa in cystic fibrosis patients? [pick all that apply]
    1. They increase biofilm stiffness.
    2. They physically protect bacteria.
    3. They increase the local pH level.
    4. They destroy cationic antibiotics.
    5. They cause bacteria to mutate.
  3. In the podcast, Michael called nitric oxide a molecular grenade for treatment of P. aeruginosa biofilms. What properties is he talking about?
    1. It adjusts the pH of the environment, killing bacteria.
    2. It inhibits production of flagella just in P. aeruginosa.
    3. It disrupts the biofilm structure and kills via oxidation.
    4. It targets P. aeruginosa by receptor binding and kills it.
  4. The main point of the paper was to test delivery of nitric oxide using cyclodextrin (CD-NO).  To do this, the researchers made a variety of thick, viscous media and compared the ability of P. aeruginosa to survive exposure to typical antibiotics or CD-NO in these media.  Survival was lower for CD-NO than typical antibiotics, particularly in the thicker medium.  If the results had instead shown that CD-NO protects P. aeruginosa, what would the results have looked like?
    1. CD-NO would have had higher survival than antibiotics.
    2. CD-NO would have had equal survival with antibiotics.
    3. CD-NO would have had lower survival with antibiotics.
    4. CD-NO would have had no survival in any medium.
  5. Cholesterol is an important biomolecule because it is used to produce ________.
    1. Pancreatic salts
    2. steroid hormones
    3. NADP and oxygen
    4. Vitamins D and E
  6. Homologs of ismA were found to be prevalent in which bacterial genus?
    1. Actinobacillus
    2. Prevotella
    3. Clostridium
    4. Brachyspira
  7. Genomic, metagenomic, and metabolomic datasets contributed greatly to this work.  Match the description and its role in this study.
Data Type Components Role in Study
a. _____ Genomic 1.This mixture has all the DNA for a single species. A. Used to identify people who had gut bacteria that produced coprostanol
b. _____ Metagenomic 2.This mixture has all the molecules present in cells. B. Used to identify the four candidate cholesterol metabolism genes
c. _____ Metabolomic 3.This mixture has all the DNAs present in an environment. C. Used to identify which bacteria were present in people with coprostanol
  1. How could you find an ismA homolog in a newly sequenced genome?
    1. Compare an ismA-containing genome to your new genome sequence.
    2. Culture the bacterium; look for the presence of high NADP levels.
    3. Culture the bacterium; test for cholesterol production using metabolomics.
    4. Search the sequence of the new genome using a known ismA sequence.

7. Figure Reading Exercises

The following are two figure reading exercises, both from the main paper (Figures 4B and 5AB).

7.1. First Figure Reading Exercise

7.1.1. Learning Objectives

Students will be able to: 

  • Identify key features of metabolomic traces and metagenomic abundance stacked bar charts.
  • Analyze the data to conclude which sample shows the greatest coprostanol production.
  • Analyze the data to conclude which sample shows the greatest abundance of IsmA+ bacteria.
  • Analyze the data to draw conclusions about the relationship of coprostanol production and IsmA+ bacteria.
Experimental Background (Kenny et al., Figure 4B)

Cholesterol levels have a large impact on human health with 4.4 million deaths per year attributed to high cholesterol (7.8% of all deaths).  Metabolism of cholesterol by gut bacteria was proposed as a mechanism to reduce serum cholesterol over 100 years ago, but this idea had been mostly overlooked until recent advancements connected the gut microbiome to health.  In this study, Kenny et al. (2020) identified a putative bacterial cholesterol-metabolizing gene which they called ismA in a species called Eubacterium coprostanoligenes.  This species can produce a metabolite of cholesterol called coprostanol and they used the sequence of this gene to identify other species present in the gut microbiome data sets that also have homologs (ismA+).  The authors hypothesized that the presence of IsmA-encoding genes in the gut microbiome gives this community the ability to metabolize/degrade cholesterol.  To test this, they used metabolomics to compare coprostanol presence (left side of panel; peak 4) to the abundance of ismA+ bacteria (right side of panel, reds) as measured by metagenomics when stool from eight healthy donors was cultured with cholesterol containing media.

Mass spectrometry traces presented alongside stacked bar charts for relative abundance. Only LD11, 04, 20, and 09 have any change.

Figure 4B.  “Cholesterol Dehydrogenase-Encoding Gut Bacteria Are Uncultured Members of Cluster IV Clostridium and Are Prevalent Across Geographically Diverse Human Populations. … (B) Ex vivo conversion of cholesterol to coprostanol by human fecal samples. Coprostanol formation occurred in 4 of the 8 samples cultured in basal cholesterol medium, with all 4 metabolizing samples containing at least one of the IsmA-encoding species identified at day 3….” (Kenny et al. 2020, figure and text cropped to include just panel B).

7.1.2. Questions

  1. Metabolomic data are presented for cultures of eight stool samples from healthy donors.  What is the notation that indicates where to expect the coprostanol peak?
    1. It is the “4” at the top of the panel.
    2. It is the peak in the metabolomic data.
    3. It is notated by a bright red arrow.
    4. It is not notated as there is no peak.
  2. Which stool sample culture produces the highest level of coprostanol?  What is your evidence?
    1. LD04; the widest peak
    2. LD11; the highest peak
    3. LD09; the narrowest peak
    4. LD20; the smoothest peak
  3. Which color indicates the abundance of bacterium msp_0196 in the metagenomic data for the stool sample cultures?
    1. gray
    2. orange
    3. Medium red
    4. Dark red
  4. Which color(s) denote(s) species in the metagenomic data that is/are IsmA+? [pick all that apply]
    1. gray
    2. orange
    3. Medium red
    4. Dark red
  5. Which stool sample culture has the largest abundance of IsmA+ bacteria?  What is your evidence?
    1. LD04; the largest non-gray bar
    2. LD11; the largest dark red bar
    3. LD09; most “red” species present
    4. LD20; the most balanced bar
  6. What can you conclude about the relationship of coprostanol production and abundance of IsmA+ bacteria in the stool sample cultures?
    1. Coprostanol is produced regardless of the presence of IsmA+ bacteria.
    2. Coprostanol production correlates with abundance of IsmA+ bacteria.
    3. When IsmA+ bacteria are present, we also see coprostanol is present.
    4. Coprostanol production occurs only in the absence of IsmA+ bacteria.

7.2. Second Figure Reading Exercise 

7.2.1. Learning Objectives

Students will be able to:

  • Identify key elements of stacked bar charts and bar graphs.
  • Analyze the odds ratio to make an interpretation related to ismA status and coprostanol presence.
  • Analyze the data to make conclusions about the relationship between coprostanol presence/absence and IsmA-encoding or non-encoding bacteria.
  • Analyze the data to make conclusions about the relationship between cholesterol and its metabolites and IsmA-encoding or non-encoding bacteria.
Experimental Background (Kenny et al., Figure 5AB)

Cholesterol levels have a large impact on human health with 4.4 million deaths per year attributed to high cholesterol (7.8% of all deaths).  Metabolism of cholesterol by gut bacteria was proposed as a mechanism to reduce serum cholesterol over 100 years ago, but this idea had been mostly overlooked until recent advancements connected the gut microbiome to health.  In addition, most of the microbial species present globally are not yet culturable in the laboratory, making studies extremely difficult.  In this study that leveraged genomic, metagenomic, and paired metabolomic datasets, Kenny et al. (2020) identified a putative bacterial cholesterol-metabolizing gene which they called ismA.  This gene encodes an enzyme that converts cholesterol to a metabolite called coprostanol.  They also used the sequence of this gene to identify other species present in the gut microbiome data sets that also had homologs (ismA+).  Due to the inability to culture many gut microbiome bacteria, their next step was to quantify the strength of the association between ismA and cholesterol metabolism by calculating an odds ratio (OR*).  The odds ratio here compares the odds of coprostanol presence (a “converter”) or absence (a “non-converter”) occurring in an ismA+ sample (an “encoder’) versus an ismA– sample (a “non-encoder”).  They used two datasets with paired metagenomic and metabolomic data from the Human Microbiome Project 2: PRISM and HPM2.  The relative abundance of encoders (maroon) and non-encoders (gray) in samples with detected coprostanol (detected) and no coprostanol (not-detected) for both datasets are displayed (panel A) with the odds ratio (OR) shown at the top of each graph.  Having completed this association study, they next wanted to investigate not only the presence of coprostanol (panel B, bottom panel), which is the final product in the proposed cholesterol degradation pathway, but also the beginning substrate (cholesterol; panel B, top panel) and an intermediate in the pathway called cholestenone (panel B, center) among encoder samples (ismA+; maroon) and non-encoder samples (ismA-; gray) for each dataset. Each dot represents a unique sample and statistical significance (p values) for relevant comparisons are shown at the top of each panel.

Stacked bar charts showing data from stool samples.

Figure 5. “ Fecal Coprostanol Formation Is Correlated to the Presence of Cholesterol Dehydrogenases in Gut Microbiomes. (A) Two independent human cohorts with paired fecal metagenomics and metabolomics were used to investigate the association between IsmA-encoding species and coprostanol formation. The presence of IsmA-encoding bacteria in the gut microbiome is highly correlated to the presence of fecal coprostanol (detected). Odds ratios for PRISM and HMP2 cohorts are 42.73 (95% CI: 11.28; 283.54) and 28.94 (95% CI: 13.64; 61.41), respectively. (B) Stool samples from patients with ismA+ species in their microbiotas have lower stool cholesterol (1), and higher cholestenone (2) and coprostanol (4) as determined by untargeted fecal metabolomics. Each point represents an independent sample with the center bar representing the mean and error bars representing SEM (PRISM: ismA+ species negative samples n = 99, positive samples n = 55, HMP2: ismA+ species negative samples n = 302, positive samples n = 169). Analysis was performed using linear (cholesterol and cholestenone) and logistic (coprostanol) regressions for PRISM and mixed effect linear (cholesterol and cholestenone) and logistic (coprostanol) models to account for repeated measures in HMP2, including the following as covariates in all models: age, gender, antibiotic usage (yes/no) and disease status (non-IBD, CD, or UC). See STAR Methods for details….” (Kenny et al. 2020, text cropped to include just panels A and B)

7.2.2. Questions

  1. Which group’s proportion is noted by the maroon sections of the bars in panel A?
    1. IsmA encoders
    2. non-encoders
    3. Coprostanol detected
    4. Coprostanol not detected
  2. How many samples total are in the coprostanol-detected group for the HMP2 data set, and how many of these are encoders (panel A)? Estimate the percentage.
    1. About 60 samples; about 10 samples were from encoders; 16%
    2. About 80 samples; about 55 samples were from encoders; 69%
    3. About 200 samples; about 10 samples were from encoders; 5%
    4. About 240 samples; about 140 samples were from encoders; 58%
  3. The strength of the association between IsmA status (encoder, non-encoder) and coprostanol presence (detected, not detected) was quantified using the odds ratio.  Which statement is correct regarding the interpretation of the odds ratio for the PRISM cohort?
    1. Samples with IsmA encoding bacteria were found 42.73% of the time compared to 58.3% for non-encoders.
    2. Samples with IsmA encoding bacteria had 42.73 % more coprostanol than samples from the non-encoders.
    3. Samples with IsmA encoders were 42.73 times more likely to have coprostanol detected than non-encoders.
    4. Samples with IsmA encoders were found in the sample set nearly equally with samples from non-encoders.
  4. Which statement best describes the results of the study regarding the association of IsmA and coprostanol presence (panel A)?
    1. There is a strong correlation between ismA+ and coprostanol presence, indicating that ismA+ microbes are likely involved in cholesterol metabolism.
    2. There is a weak correlation between encoding ismA genes and the presence of coprostanol, indicating that these microbes do not degrade cholesterol
    3. There is a strong correlation between encoding ismA genes and the presence of cholesterol, indicating that microbes degrade cholesterol to coprostanol.
    4. There is a weak correlation between the presence of coprostanol and the presence of cholesterol, indicating that microbes do degrade cholesterol.
  5. The researchers decided to quantify another compound, cholestenone.  What is the relationship of this molecule to cholesterol and coprostanol?
    1. Cholestenone is the end product in the cholesterol metabolism pathway.
    2. Cholestenone is a control molecule to compare to the other molecules.
    3. Cholestenone is an intermediate in the cholesterol metabolism pathway.
    4. Cholestenone is the product of a second cholesterol metabolism pathway.
  6. The levels of cholesterol, cholestenone, and coprostanol are segregated by IsmA-encoders and non-encoders in each dataset (panel B).  Which color bar and which text notation indicates the samples are from the IsmA encoders?
    1. Maroon, negative
    2. Maroon, positive
    3. Gray, negative
    4. Gray, positive
  7. Which statement(s) describe(s) the results of the study regarding the presence of IsmA+ bacteria and the different cholesterol pathway compounds (panel B)? [pick all that apply]
    1. Encoder samples have more cholesterol than non-encoder samples.
    2. Encoder samples have more cholestenone than non-encoder samples.
    3. Encoder samples have more coprostanol than non-encoder samples.
    4. When cholesterol is high, cholestenone and coprostanol are high.
    5. When cholesterol is lower, cholestenone and coprostanol are higher.
  8. Taken together, what can you conclude about the results shown in these experiments?
    1. There is strong support that IsmA blocks cholesterol uptake from the digestive tract into serum.
    2. There is strong support that IsmA-encoding microbes are involved in cholesterol metabolism.
    3. There is strong support that cholesterol is directly metabolized to cholestenone and coprostanol.
    4. There is strong support that ismA encodes an enzyme converting cholestenone to coprostanol.

8. Paper Information and Licensing

8.1. Snippet paper

  • Rouillard KR, Markovetz MR, Bacudio LG, Hill DB, Schoenfisch MH. 2020. Pseudomonas aeruginosa Biofilm Eradication via Nitric Oxide-Releasing Cyclodextrins. ACS Infectious Diseases. 6(7):1940–1950. doi: 10.1021/acsinfecdis.0c00246
  • This article is not licensed for Creative Commons use, see the article on the journal’s web page. Thus, the abstract and figures cannot be copied here. Please see the article at the journal’s web page.

8.2. Main paper

  • Kenny DJ, Plichta DR, Shungin D, Koppel N, Hall AB, Fu B, Vasan RS, Shaw SY, Vlamakis H, Balskus EP, et al. 2020. Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level. Cell Host & Microbe. 28(2):245-257.e6. doi: 10.1016/j.chom.2020.05.013.
  • This article is licensed for Creative Commons usage with CC BY 4.0, which allows re-use and adaptation with proper attribution and notation of any changes, see the article’s copyright information.

License

Icon for the Creative Commons Attribution 4.0 International License

Podcast Annotation and Resources in Microbiology Copyright © 2025 by Rebecca Seipelt-Thiemann; Nancy Boury; Gwendowlyn S. Knapp; Amaya Garcia Costas; and Patrick Armstrong is licensed under a Creative Commons Attribution 4.0 International License, except where otherwise noted.

Share This Book